Burlington, Mass.-based Tufts Medicine has named Rachel Verville senior vice president of revenue cycle, according to a Dec. 17 post on her LinkedIn page.
Category: Static
Google, Suki partner on clinical assistant
Suki and Google Cloud are advancing clinical support technology to include patient summaries and a question-and-answer functionality.
New York cancer center opens $98M cell, gene therapy hub
Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center opened a $98 million cell and gene therapy hub aimed at growing the center’s capabilities for cancer cell therapy research.
2023 chemotherapy shortage did not affect mortality rates: 6 study notes
A 2023 shortage of the generic platinum-based chemotherapy drugs cisplatin and carboplatin had no effect on cancer mortality rates, according to a study published Dec. 3 in the Journal of the National Cancer Institute.
PBMs secretly profited from opioid crisis: New York Times
Pharmacy benefit managers were paid by drugmakers, including Purdue Pharma, to keep opioid prescriptions flowing even as overdose deaths soared across the U.S., according to an investigation by The New York Times.
Tufts Medicine reports $68.2M operating loss, -10.2% margin in Q3
Burlington, Mass.-based Tufts Medicine reported an operating loss of $68.2 million (-10.2% margin) in the third quarter, compared to a $61 million loss (-9.6% margin) recorded in the same period in 2023.
New Mexico hospital names COO
Mary Armijo has been appointed COO of Lovelace Medical Center in Albuquerque, N.M., effective Jan. 6.
U of Utah Health taps Mass General surgeon as CEO
Bob Carter, MD, PhD, has been named CEO of Salt Lake City-based University of Utah Health and senior vice president for health sciences at the University of Utah, effective mid-February.
RWJUH Rahway taps chief administrative officer
Eric Kleinert, MSN, RN, has been named chief administrative officer of Robert Wood Johnson University Hospital Rahway (N.J.), effective Dec. 31.
9 'boomerang' CEOs in 2024
While many hospital and health system CEOs who took on new roles in 2024 switched organizations or facilities, a few stood out for returning to a former workplace.
